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Cytosolic lipid droplets (LDs) are observed in enterocytes of jejunum during lipid absorption. One im-
portant function of the intestine is to secrete chylomicrons, which provide dietary lipids throughout the
body, from digested lipids in meals. The current hypothesis is that cytosolic LDs in enterocytes constitute
a transient pool of stored lipids that provides lipids during interprandial period while lowering chylo-
micron production during the post-prandial phase. This smoothens the magnitude of peaks of hyper-
triglyceridemia. Here, we review the composition and functions of lipids and associated proteins of
enterocyte LDs, the known physiological functions of LDs as well as the role of LDs in pathological
processes in the context of the intestine.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
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Fig. 1. Biogenesis and fate of cytosolic lipid droplets (LDs) and chylomicrons in enterocytes. (A) Biogenesis of cytosolic LDs and chylomicrons. Newly synthesized triglycerides
(TG) accumulate between the two leaﬂets of the endoplasmic reticulum (ER) membrane. Nascent LDs bud off the ER membrane either into the cytosol to give cytosolic LDs or
into the ER lumen to give luminal lipid droplets. Luminal lipid droplets fuse with apolipoprotein B48 (apoB48) to form chylomicrons. LD-associated proteins surround
cytosolic LDs. (B) During the postprandial phase (top panels), digested lipids are taken up by enterocytes, TGs are synthesized at the ER membrane and, after assembly,
chylomicrons are secreted at the basal pole of enterocytes in lymphatic vessels. After a high fat meal (right panel), a portion of synthesized lipids is stored in cytosolic LDs.
During the interprandial phase (bottom panel), TG from cytosolic LDs are mobilized for chylomicron formation. (C) The physiological function of the transient lipid storage in
cytosolic LDs is thought to provide sustained lipid supply to organs and smoothen hypertriglyceridemia curve as a function of time after a high fat meal.
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One of the major functions of the intestine is to absorb nu-
trients, including lipids. The absorption of dietary lipids occurs
mainly in the jejunum, a part of the proximal small intestine, and
this is performed by enterocytes as a highly specialized and
complex process (for review, see [1,2]). Brieﬂy, dietary lipids
(mainly triglycerides (TG), but also cholesterol esters (CE) and
phospholipids (PL)) are digested in the upper part of the small
intestine into fatty acids (FAs), monoacylglycerols, lysopho-
spholipids and cholesterol. The digested lipids present in the lu-
men of the jejunum are taken up by enterocytes mostly by passive
diffusion but also by transporters. Inside the cell, TG and PL aresynthesized at the endoplasmic reticulum (ER) membrane and will
contribute to chylomicron formation. Chylomicrons, the intestinal
triglyceride-rich lipoprotein (TRL), are formed in the ER lumen by
the fusion of one particle composed of apolipoprotein B48
(apoB48) stabilized by a small amount of PL and of a luminal lipid
droplet present in the lumen of the ER (Fig. 1A). The nascent
chylomicrons are transferred by vesicular transport to the Golgi
apparatus then secretory vesicles and are ﬁnally secreted at the
basal pole of the cell, into the lymphatic system (Fig. 1B). In the
circulation, chylomicrons are metabolized by lipoprotein lipase,
which provides fatty acids (FAs) to cells, including adipocytes.
Chylomicron remnants, depleted from lipids, will be taken up by
the liver and degraded.
Table 1
Proteins identiﬁed by proteomic analyses or western blot in lipid droplet fractions isolated from enterocytes (animal or cellular models) and involved in metabolism-related
processes of lipids and hydrophobe molecules. When the localisation on or around lipid droplets has been visualized by confocal or electron microscopy, proteins are in bold
type.
Gene UniProt Protein name Refs
ABHD5/CGI-58 ABHD5_HUMAN α/β Hydrolase domain 5/comparative gene identiﬁcation-58 [9]
ACSL3 ACSL3_HUMAN Long chain acyl-CoA synthetase 3 [9,16]
ACSL4 ACSL4_HUMAN Long chain acyl-CoA synthetase 4 [9]
ACSL5, Acsl5 ACSL5_HUMAN, ACSL5_MOUSE Long chain acyl-CoA synthetase 5 [16,17]
Adh1 Q3UKA4_MOUSE Alcohol dehydrogenase 1 [17]
Aldh1a1 AL1A1_MOUSE Retinal dehydrogenase 1 [17]
ANXA2, Anax2 ANXA2_HUMAN, ANXA2_MOUSE Annexin A2 [9,17]
ANXA4, Anax4 ANXA4_HUMAN, Q7TMN7_MOUSE Annexin A4 [9,17]
Apoa1 Q3V2G1_MOUSE Apolipoprotein A-I [17]
APOA4, Apoa4 APOA4_HUMAN, Q9DBN0_MOUSE Apolipoprotein A-IV [9,17]
Apob APOB_MOUSE Apolipoprotein B [17]
APOE APOE_HUMAN Apolipoprotein E [9]
Atp5a1 ATPA_MOUSE ATP synthase subunit alpha, mitochondrial [17]
Atp5b ATPB_HUMAN, ATPB_MOUSE ATP synthase subunit beta, mitochondrial [9,17]
B4galnt2 B4GN2_MOUSE Beta-1,4 N-acetylgalactosaminyltransferase 2 [17]
Bpnt1 BPNT1_MOUSE 3(2),5-bisphosphate nucleotidase 1 [17]
Cat Q8C6E3_MOUSE Catalase [17]
Ces2a EST2A_MOUSE Pyrethroid hydrolase [17]
Ces2c EST2C_MOUSE Acylcarnitine hydrolase [17]
Ces2e EST2E_MOUSE Pyrethroid hydrolase [17]
cideb CIDEB_MOUSE Cell death activator CIDE-B [46]
Clint Q5SUH7_MOUSE Clathrin interactor 1 [17]
Cyb5a CYB5_MOUSE Cytochrome b5 [17]
CYB5R3, Cyb5r3 NB5R3_HUMAN, NB5R3_MOUSE NADH–cytochrome b5 reductase 3 [9,16,17]
Cyp2b10 Q9WUD0_MOUSE Cytochrome P450 2B10 [17]
Dbi Q548W7_MOUSE Diazepam binding inhibitor, Acyl-CoA-binding protein [17]
DHCR7 DHCR7_HUMAN 7-Dehydrocholesterol reductase [9]
DHRS1 DHRS1_HUMAN Dehydrogenase/reductase SDR family member 1 [9,16,17]
DHRS3 DHRS3_HUMAN Short-chain dehydrogenase/reductase 3 [9,16]
ELMOD2 ELMD2_HUMAN ELMO domain-containing protein 2 [9]
ECHS1 ECHM_HUMAN Enoyl-CoA hydratase, mitochondrial [9]
EPHX1 HYEP_HUMAN Epoxide hydrolase 1 [9]
Ephx2 Q3UQ71_MOUSE Bifunctional epoxide hydrolase 2 [17]
Fabp1 Q3V2F7_MOUSE Fatty acid-binding protein, liver [17]
Fabp2 Q53YP5_MOUSE Fatty acid-binding protein, intestinal [17]
FAF2/UBXD8 FAF2_HUMAN FAS-associated factor 2/UBX domain-containing protein 8 [9,16]
Golm1 GOLM1_MOUSE Golgi membrane protein 1 [17]
Hadh HCDH_MOUSE Hydroxyacyl-coenzyme A dehydrogenase [17]
HSD17B2 DHB2_HUMAN Estradiol 17-beta-dehydrogenase 2 [16]
HSD17B7 DHB7_HUMAN 3-Oxo-steroid reductase [9,16]
HSD17B11, Hsd17b11 DHB11_HUMAN, DHB11_MOUSE Oestradiol 17-β-dehydrogenase 11 [9,16,17]
HSD3B1 3BHS1_HUMAN 3-β-Hydroxysteroid dehydrogenase [9,16]
HSPA8, hspa8 HSP7C_HUMAN, HSP7C_MOUSE Heat-shock cognate 71 kDa protein [9,17]
Lipe LIPS_MOUSE Hormone-sensitive lipase [12,17]
LDAH/C2orf43 LDAH_HUMAN Lipid droplet-associated hydrolase (previously UPF0554 protein C2orf43) [9,16]
LPCAT2 PCAT2_HUMAN Lysophosphatidylcholine acyltransferase 2 [9,16]
LSS ERG7_HUMAN Lanosterol synthase [9,16]
MGLL MGLL_HUMAN Monoglyceride lipase [9,16]
Mogat2 MGAT2_MOUSE 2-acylglycerol à-acylltransferase 2, Monoacylglycerol: acylCoA transferase 2 [12]
MTTP, Mttp MTP_HUMAN, MTP_MOUSE Microsomal triglyceride transfer protein [9,12,16,17]
NSDHL NSDHL_HUMAN Sterol-4-α-carboxylate 3-dehydrogenase, decarboxylating [9,16]
P4HB PDIA1_HUMAN Protein disulphide-isomerase [9,16,17]
PCYT1A PCY1A_HUMAN Choline-phosphate cytidylyltransferase A [9]
PLIN2, Plin2 PLIN2_HUMAN, PLIN2_MOUSE Perilipin 2/ADRP [7,9,12,16]
PLIN3, Plin3 PLIN3_HUMAN, PLIN3_MOUSE Perilipin 3/TIP47 [7,9,16,17]
PNPLA2, Pnpla2 PLPL2_HUMAN, PLPL2_MOUSE Patatin-like phospholipase domain-containing protein 2 [9,12,16]
Prdx6 Q6GT24_MOUSE Peroxiredoxin-6 [17]
PTGS2 PGH2_HUMAN Prostaglandin G/H synthase 2, cyclooxygenase-2 [15]
Rbp2 RET2_MOUSE Retinol-binding protein 2 [17]
RDH10 RDH10_HUMAN Retinol dehydrogenase 10 [9,16]
Scp2 NLTP_MOUSE Non-speciﬁc lipid-transfer protein [17]
SGPL1 SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 [9]
SQLE ERG1_HUMAN Squalene monooxygenase [16]
Sult1b1 ST1B1_MOUSE Sulfotransferase family cytosolic 1B member 1 [17]
Ugt1a7c UD17C_MOUSE UDP-glucuronosyltransferase 1–7C [17]
F. Beilstein et al. / Experimental Cell Research 340 (2016) 172–179174Cytosolic lipid droplets (i.e. LDs present in the cytosol, which
will be referred to as LD throughout this review) are observed in
enterocytes of jejunum primarily if not only during lipid absorp-
tion (for review, see [3]). The minimal deﬁnition of a lipid droplet
is a core of neutral lipids surrounded by a monolayer ofamphipatic lipids and associated proteins. The current hypothesis
is that cytosolic LDs in enterocytes constitute a transient pool of
stored lipids that help optimize lipid absorption during food
consumption and provide sustained lipid supply during fasting
(Fig. 1B and C). Present in different intracellular compartments,
F. Beilstein et al. / Experimental Cell Research 340 (2016) 172–179 175cytosolic LDs and chylomicrons are both composed of a core of
neutral lipids (TG and CE) surrounded by a monolayer of PLs and
cholesterol, and of associated proteins: LD-associated proteins for
cytosolic LDs and apolipoproteins for chylomicrons. For a long
time, researchers paid far more attention, in enterocyte, to highly
specialized chylomicrons than to cytosolic LDs, considered as inert
lipid storage depot. LDs became objects of interests, ﬁrst in adi-
pocytes, when in 1990 C. Londos showed for the ﬁrst time that
upon induction of lipolysis a LD-associated protein was phos-
phorylated, indicating a regulatory process on LDs [4]. Nowadays,
LDs are recognized as genuine organelles, highly dynamic, in close
relation with other organelles [5], with more and more biological
functions [6]. Later, in 2009 perilipins, the LD coat proteins, were
characterized in enterocytes. In these cells, LDs are strongly altered
by meal and diet [7–9].
The biogenesis of LDs is widely accepted as being the accu-
mulation of newly synthesized TG between the two leaﬂets of the
ER phospholipid bilayer [10,11] (Fig. 1A). In any cell type, the
nascent LD buds off the ER into the cytosol while, in hepatocytes
and enterocytes, it can bud also towards the ER lumen where TRL
assembly takes place. The mechanisms that control the lipid dis-
tribution between the cytosol and the ER lumen are still unclear.
Most of our knowledge about LDs came from studies performed in
adipocytes, a cell type specialized in lipid storage and fatty acid
(FA) supply to the body at distance of meals. In fact, almost any cell
type can produce LDs and, while common features exist, it is be-
coming clear that the LDs composition and functions are different
among cell types and need to be clariﬁed.
In this review, we will present the composition of cytosolic LDs
in enterocytes then we will focus on the speciﬁc physiological
functions of the lipids and the LD-associated proteins in the con-
text of the enterocyte. We will restrict our review to the proteins
that have been demonstrated to be functionally associated to LDs
in enterocytes, or to other cell types when relevant. We will then
discuss the potential roles that enterocytes LDs may have in health
and diseases.2. Lipid droplets in enterocytes: composition, speciﬁc func-
tions of lipids and associated proteins
2.1. Lipids and hydrophobic molecules
A detailed lipid analysis of LDs isolated from the mucosa of
mouse proximal intestine was performed four hours after inges-
tion of sunﬂower oil containing 2% cholesterol [12]. TG, dia-
cylglycerols (DAG), free cholesterol and CE were the major lipids,
but sphingomyelines, phosphatidylcholines and ceramides were
also present in LDs in signiﬁcant amounts. PC content was similar
to values found in LDs isolated from 3T3L1 adipocytes [13]. The
size of the LDs was heterogeneous, large LDs contained most of the
lipids including DAGs while the smallest LDs were enriched in
cholesterol and CE [12]. The length chain of the predominant fatty
acid identiﬁed in LDs was that of the ingested sunﬂower oil (C18),
which underlines the close connection between dietary fat ab-
sorption and LDs showing up [8,9].
Enterocytes, like other cell types, may use FAs and cholesterol
of LDs for their own purposes, energy production or membrane
biosynthesis. FAs can exert cytotoxicity that is prevented during
lipid absorption by enterocytes by the synthesis and storage of TGs
into LDs. In cytosolic LDs, there is a clear dynamic accumulation of
TG followed by depletion during lipid absorption [8,9,14]. The
density and size of LDs along the small intestine has been quan-
tiﬁed as a function of time after lipid gavage in mice, by coherent
anti-Stokes Raman scattering (CARS) imaging [8]. It suggests that
the dynamic, cytosolic LD pool in enterocytes may contribute tothe regulation of postprandial blood TG concentrations (Fig. 1B and
C). A role of LDs in response to inﬂammatory stimuli in enterocytes
is poorly documented but can be suspected due to links with
production of prostaglandins, which are lipid mediators in in-
ﬂammation [15]. Moreover, the favoured hydrophobic environ-
ment of LDs allows to store/metabolise hydrophobic molecules
including lipophilic vitamins and xenobiotic compounds, which
are abundant in the digested food present in the lumen of the
jejunum (for review, see [3]).
2.2. Lipid droplet-associated proteins
Three proteomic studies have been published so far for en-
terocyte LDs after lipid challenges [9,16,17]. The two ﬁrst studies
were performed from LDs isolated from Caco-2 cells incubated for
24 h with lipid micelles [9,16]. This cell line differentiates into
enterocyte-like cells that share many of the characteristics of ab-
sorptive enterocytes, including TRL secretion and LD accumulation
after lipid challenge [18–20]. The third study was performed from
jejunum epithelium of mice two hours after an olive oil bolus [17].
In these studies, up to 200 proteins were identiﬁed and 20–25%
were linked to lipid metabolic pathways (Table 1), a percentage
similar to that found in adipocytes [21,22]. As in other cell types,
the vast majority of the identiﬁed proteins are involved in biolo-
gical processes such as membrane trafﬁcking, protein folding,
signalling pathways, carbohydrate metabolism, translation, etc…,
which suggest LDs functions well beyond lipid metabolism.
Moreover, proteins from multiple subcellular compartments in-
cluding ER, mitochondria, lysosomes, autophagosomes and cytosol
were also identiﬁed in LDs from enterocytes as in other cell types
[5].
From a list of proteins identiﬁed by mass spectrometry, it is
important to distinguish between contamination and bona ﬁde LD
proteins. This is particularly true for enterocytes whose cytoplasm
is very rich in organelles. On the one hand, contaminants may be
present because LDs are in very close interaction or in continuity
with organelles. On the other hand, stringent conditions can be
used for LDs isolation to avoid contamination but loosely bound
LD proteins can then be lost. Moreover, recent studies showed that
monotopic hairpin membrane proteins such as diacylglycerol
acyltransferase 2 (DGAT2), ancient ubiquitous protein (AUP), ly-
sophosphatidylcholine acyltransferase (LPCAT) 1 and 2, etc. are
able to insert into a PL bilayer as well as in a PL monolayer, i.e. to
ER or to LDs [23–25]. Accordingly, the association of a protein
identiﬁed by proteomics to LDs must be validated by other
methods.
Table 1 lists the proteins that have been identiﬁed so far by
mass spectrometry on LDs isolated from enterocytes and that are
in connection with lipid and hydrophobic molecules [9,16,17]. In
the section below, we will focus on proteins whose association to
enterocyte LDs is well documented. These proteins are mainly
related to lipid metabolism.
2.2.1. Perilipins, the structural proteins
The perilipin (Plin) family quantitatively represents the most
abundant signature of the LD machinery. Perilipins are a multi-
protein family (5 members) that targets lipid droplet surfaces and
regulates lipid storage and hydrolysis [26]. While Plin1 is almost
only expressed in adipocytes, there is no perilipin isoform speciﬁc
for enterocytes. Plin2 (previously ADRP, adipophilin) and Plin3
(previously TIP47) are ubiquitous, including in enterocytes [7,9].
Plin2 is higher after a chronic than an acute high-fat challenge in
mouse enterocytes and Plin2 amount is increased after a 24h-lipid
supply to Caco-2 cells [7,9]. Plin3 is present in enterocytes from
chow and high-fat challenged mice [7]. Contrary to Plin2, Plin3
amount is higher after an acute than a chronic fat challenge. By
F. Beilstein et al. / Experimental Cell Research 340 (2016) 172–179176proteomic analysis, D’aquila et al. [17] identiﬁed only Plin3 on LDs
isolated from jejunum enterocytes after an olive oil bolus to mice.
Overall, results suggest that Plin3 is preferentially associated to
transient lipid storage while Plin2 is associated with more pro-
longed lipid storage. Furthermore, recent studies in total Plin2 KO
mice fed with low or high fat diet for 4 days showed that Plin2 KO
mice had decreased LDs in enterocytes and increased faecal tri-
glyceride levels compared to wild type mice [27]. Interestingly,
these Plin2 KO mice had an altered intestinal microbiome as
compared to wild type mice. The impact of Plin2 deﬁciency on
chylomicron secretion was not examined. Overall, Plin2 deﬁciency
appears to decrease the lipid storage capacity in LDs, which leads
to impaired FA uptake by enterocytes.
2.2.2. Proteins involved in hydrolysis/synthesis of triglycerides, and
in lipid secretion
Several enzymes involved in TG metabolism were identiﬁed on
LDs [9,12,16,17]. For TG hydrolysis, these proteins are the adipose
triglyceride lipase (ATGL), and its co-activator CGI-58, that hy-
drolyses TG into diacylglycerol and FAs, the hormone sensitive-
lipase (HSL) that hydrolyses diacylglycerol into monoacyglycerol
and FAs, and the monoacyglycerol lipase (MGL) that hydrolyses
monoacylglycerol into glycerol and FAs (for review, see [28]).
These lipids are substrates of monoacylglycerol acyltransferases
(MGATs) and diacylglycerol acyltransferases (DGATs) for re-
synthesis of triglycerides. Some of their functions have been stu-
died by invalidation in mouse models.
Speciﬁc intestinal KO mice for ATGL had increased intracellular
LDs in the intestinal epithelium but unchanged TG absorption
from intragastric administration of triolein, suggesting that ATGL
hydrolyses TGs from LDs but these lipids are not dedicated to
chylomicron production in the small intestine [29]. Moreover,
ATGL deﬁciency led to a down-regulation of target genes of PPARα,
which is a transcription factor that is activated by FAs. This re-
sulted in particular in delayed cholesterol absorption [29]. Re-
cently, ELMOD2 (ELMO domain-containing protein 2), a putative
noncanonical Arf-GTPase activating protein (GAP) anchored by
palmitoylation on LDs isolated from Caco-2 cells was shown to
down-regulate ATGL recruitment by suppressing the Arf1-COPI
activity in LDs in hepatic Huh-7 cells [30]. Arf1/COPI can bud
nano-LDs (∼60 nm diameter) from PL-covered oil/water interfaces
in vitro. This triggers the formation of LD-ER membranes bridges,
enabling rapid monotopic protein targeting to LDs including ATGL
and DGAT2 [31]. Accordingly, ELMOD2 depletion leads to de-
creased density and size of LDs. The role of ELMOD2 in the control
of TRL secretion has not been examined yet. Intestinal CGI-58
(ATGL co-activator) knockout mice led to large LDs accumulation
in enterocytes even during the fasting state, increased TG and CE
intestinal content and decreased postprandial plasma TG con-
centration [32]. Intestinal CGI-58 appears thus required for efﬁ-
cient postprandial TRL secretion. Global MGL deletion in mice led
to a markedly reduced intestinal TG secretion following an oral fat
challenge, suggesting delayed lipid absorption [33]. Thus, in-
testinal depletion of enzymes involved in TG hydrolysis leads to LD
accumulation in enterocytes.
In enterocytes, the prominent TAG synthesis pathway during
lipid absorption is the MGAT pathway involving MGATs and DGATs
[1,2]. These enzyme activities are present at the ER membrane.
However, MGAT2, highly expressed in the proximal small intes-
tine, was recently evidenced on isolated LDs from mouse en-
terocytes by western blotting suggesting that LDs may be a site for
DAG synthesis as well [12]. Intestinal MGAT2 deﬁciency did not
impair the amount of fat absorbed but reduced the rate of entry of
dietary fat into the circulation [34]. This reduced rate led to more
fat reaching the distal intestine and, in mice fed a high-fat diet,
clusters of LDs were observed in the mid-intestine of KO mice butnot in wild type. In intestine, at least two enzymes are responsible
for DGAT activity: DGAT1, exclusively localized at the ER mem-
brane, and DGAT2, which has also been identiﬁed on LDs of var-
ious cell types including differentiated 3T3-L1 adipocytes [35,24].
Intestinal DGAT2 overexpression in mice resulted in increased TG
secretion but TG storage in LDs was similar to wild type mice [36].
However, in the conditions tested, none of the proteomic studies
identiﬁed DGAT2 on LDs isolated from enterocytes [9,16,17]. The
respective contribution of the presence of these enzyme activities
on ER and/or LDs to enter cellular metabolic pathways (oxidation
for energy production, lipid storage, chylomicron production)
needs to be addressed.
FAs need to be activated by ACSLs (acyl-CoA synthetase long-
chain) before entering any metabolic pathway. ACSL3 and ACSL5
were identiﬁed on LDs isolated from enterocytes (Table 1). Recent
studies showed that overexpression of ACSL3a (orthologous to
human ACSL3) in enterocytes leads to accumulation of cytoplasmic
LDs and delays, in part, the appearance of neutral lipids in the
vasculature of zebraﬁsh larvae [37]. In hepatic Huh-7 cells, ACSL3
was shown to be required for incorporation of FA into phospha-
tidylcholine and ACSL3 depletion resulted in decreased secretion
of TRL [38]. Cytosolic LDs were not examined in this study. Thus
ACSL3 and ACSL5 functions in intestinal lipid absorption and LDs
are still unclear.
Cell death-inducing DFF45-like effector (CIDE) family play a
role in regulating various aspects of lipid metabolism [39]. While
Cidea and Cidec are expressed in adipose tissue, enterocytes ex-
press Cideb but this protein was not found in proteomics studies.
However, Cideb was shown localised both on ER and LDs by HA-
and GFP- expressed Cideb [40]. After olive oil gavage, Cideb-deﬁ-
cient mice exhibited increased LDs accumulation, decreased lipid
secretion and size of chylomicrons, and increased faecal lipids.
Conversely, overexpression of Cideb reduced lipid accumulation in
Caco-2 cells and enhanced lipid secretion. Overall, Cideb appears
to decrease transient lipid storage in LDs and facilitate the lipi-
dation of chylomicrons [40].
Chylomicrons contain apoB, the constitutive apolipoprotein,
and apoA-1 and apoA-IV, exchangeable apolipoproteins. Their as-
sembly requires microsomal triglyceride transfer protein (MTP) for
apoB stabilisation by lipidation and luminal lipid droplet produc-
tion in the ER lumen (Fig. 1A). ApoB, apoA-1 and apoA-IV were
identiﬁed in isolated cytosolic LDs from enterocytes in all pro-
teomic studies (Table 1). ApoA-IV, speciﬁcally expressed by en-
terocytes and induced upon lipid supply, was showed to be closely
associated to LDs by confocal microscopy and electron microscopy
[9,17]. Although this feature may be due to mere contamination of
LDs by ER, we have to keep in mind that LDs are generated from ER
and they can remain physically linked to ER or in very close
proximity [5,10,11]. The physical interactions between ER and LD
may well illustrate the strong functional interactions necessary for
lipoprotein production, as suggested by Beilstein et al. [16].
2.2.3. Proteins involved in autophagy of lipid droplets (lipophagy)
Lipophagy, ﬁrst described in hepatocytes, is now known to
contribute to mobilization of intracellular lipid stores in many cell
types [41]. Lipophagy occurs in enterocytes too [42,43]. Upon lipid
micelles supply, an autophagic response is rapidly induced in
Caco-2 cells and autophagy inhibition leads to TG accumulation as
intracellular LDs, and to accumulation of CE [42]. Furthermore,
while inhibition of autophagy has a mild effect on lipid secretion
via TRL, it strongly increased high-density lipoproteins (HDL)
production, which is responsible of the reverse transport of cho-
lesterol from peripheral tissues to the liver.
In cell lines and mouse liver in vivo, it has been shown recently
that degradation of LD-associated proteins (perilipins) by chaper-
one-mediated autophagy facilitates lipolysis [44]. Heat shock
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process, was identiﬁed in abundance in isolated LDs of Caco-2 cells
[9]. Further work needs to be done to decipher the exact role of
autophagy in the context of regulation of cellular lipid metabolism
of enterocytes [41].
2.2.4. Proteins involved in cholesterol and steroid hormone
metabolism
The biosynthesis and intracellular trafﬁc of cholesterol is
complex and even more in enterocytes because dietary cholesterol
is absorbed from the intestinal lumen and secreted in lipoproteins,
and because the body cholesterol is eliminated through trans-in-
testinal cholesterol efﬂux (TICE), an alternative route to cholesterol
excretion by bile acid secretion [45,46]. Lanosterol synthase and
NAD(P)-dependent steroid dehydrogenase-like (NSDHL), which
operate in the late steps of cholesterol biosynthesis, were identi-
ﬁed on isolated LDs. C2orf43, recently characterized as a choles-
terol ester esterase in macrophages and named LD-associated
hydrolase (LDAH) [47], is identiﬁed and localizes around LDs in
Caco-2 cells [16]. These results suggest that LDs contribute to
cholesterol metabolism in enterocytes.
It is noteworthy that several proteins identiﬁed in isolated LDs
from enterocytes are linked to steroid hormones metabolism
(Table 1). The localization at the LD surface is conﬁrmed for some
of them [NSDHL, 17β-hydroxysteroid dehydrogenase 2 (DHB2), 3-
β-hydroxysteroid dehydrogenase 1 (3BHS1)]. The identiﬁcation of
enzymes involved in steroid hormones metabolism was surprising
because intestine is not reputed as a steroidogenic organ [48], as is
adipose tissue [49,50]. The local production of steroid hormones
by peripheral tissues is now thought to play important roles in
tissue homoeostasis. We have recently shown that DHB2, which
catalyzes the conversion of 17-keto (e.g. estrone, testosterone) to
17β-hydroxysteroid (e.g. estradiol, androstenedione), is localized
to LDs and interferes with TG secretion, probably through its ca-
pacity to inactivate testosterone [16]. We thus identiﬁed a novel
modulator of TRL production.
On top of their function, several of the enzymes belonging to
the Short chain/dehydrogenase/reductase (SDR) family metabolize
various compounds including steroids, retinoids, fatty acid deri-
vatives and xenobiotic molecules [51]. Though liver is traditionally
considered to be the major xenobiotic compounds-metabolizing
organ, enterocytes are in contact with a large variety of xenobiotic
molecules present in diet and may contribute to the detoxiﬁcation
process.3. Involvement of lipid droplets of enterocytes in pathological
processes
Several genes listed in Table 1 are responsible of human genetic
diseases. Most proteins associated to LDs, if not all, are not speciﬁc
of enterocytes. The diseases affect primarily other organs and little
attention has been paid to date to the symptoms affecting the
intestine itself. In this section, we chose to focus on diseases af-
fecting speciﬁcally enterocytes and intestine.
3.1. Lipids droplets and metabolic health and diseases
As detailed in the previous section, an overexpression or de-
letion of several proteins associated to enterocyte LDs led to an
altered size or density of cytosolic LDs, but also to modiﬁcations of
lipoprotein secretion (amount or secretion rate) and/or to changes
of lipid amounts remaining in the intestinal lumen, i.e. lipids
eventually measured in faeces. A positive correlation exists be-
tween post-prandial serum lipid levels and coronary artery dis-
eases [52]. The possibility of controlling the lipid output over timein the circulation by controlling the transient storage of the lipids
in cytosolic LDs makes LDs as promising potential therapeutic
targets (Fig. 1).
The alteration of diet lipid content may alter the LDs char-
acteristics of enterocytes in the small intestine. In turn, the pre-
sence of lipids in the lumen of the intestine affects the microbiota
composition. A high-fat diet inﬂuences the types and amounts of
gut microbes, which have been implicated in the development of
diet-induced obesity, chronic inﬂammation and insulin resistance
(for review, see [53]). A high-fat palm oil diet induced an up-
regulation of lipid metabolism-related genes in the distal small
intestine compared to a low fat palm oil diet or high-fat olive oil or
safﬂower diets. The same occurs for many proteins associated to
LDs such as DGAT2, ACSL3, ACSL5, HSD17B11, MTTP, apoB, apoA-IV,
and PCY1A [54]. Additionally, enterocytes, which have a life of only
5 to 7 days, are eliminated into the intestinal lumen where their
content, including LDs, might feed the gut microbiota present
downstream.
In Humans, mutations of proteins found on LD have been as-
sociated with pathologies. CGI-58 mutation, as an example, causes
Chanarin-Dorfman syndrome, an autosomal recessive genetic
disease characterized by massive accumulation of TGs in the cy-
tosolic LDs in most cell types, including absorptive enterocytes of
small intestine.
A genetic variation in human PLIN2, Ser251Pro polymorphism,
is associated with decreased concentrations of plasma TG and very
low density of lipoproteins (VLDL), the TRL secreted by hepato-
cytes [55]. When transfected to HEK293 cells, this variant leads to
increased lipid accumulation and decreased lipolysis. Plin2 de-
creases ATGL access to LD surface and thus TG hydrolysis [26]. It is
suggested that this variant may affect lipases and/or their mod-
ulators to associate with LDs and hence reduce lipolysis. Further-
more, this variant leads to increased Plin3 expression, the other
perilipin expressed in enterocytes. It would be interesting to
measure the postprandial triglyceridemia in these human subjects
fed a high-fat meal or diet to assess the impact of this Plin2
polymorphism in intestine, and to look for possible correlations
with insulin resistance, obesity and cardiovascular diseases.
3.2. Lipid droplets and viral infections
Knowledge on gut virome is still scarce [56]. However, several
viral intestinal pathogens have been shown to use LDs for their
production, and LDs may thus be involved in their pathogenesis.
Rotaviruses and enteroviruses are well known in clinical practice
and are known to be responsible for common infectious
gastroenteritis.
Rotaviruses, the most common cause of infectious diarrhoea
among infants and young children, infect enterocytes on the tips
of the intestinal villi. Morphogenesis takes place in cytoplasmic
inclusion bodies known as viroplasms, which colocalize and in-
teract with LDs. Compounds disrupting or blocking LDs inhibit
viral replication [57–59].
Human parechovirus (HPEV-1) cause mild gastrointestinal or
respiratory illness. In infected cells, the non-structural viral pro-
teins 2C and 2BC are mainly localized to the surface of LDs [60].
Like the NS5A protein of hepatitis C virus (HCV), a virus which
hijacks hepatic lipid metabolism for its replication, the N-terminal
region of the picornaviral 2C protein folds into an amphipathic α-
helix, which is responsible for the proteins association with
membranes in the viral RNA replication complex [61].
In Caco-2 cells, the expression of HCV core protein, which as-
sociates to the LD surface, results in decreased lipoprotein secre-
tion [16]. This is similar to what is observed in hepatocytes and in
HCV-infected patients.
Enteroviruses exploit the clathrin-mediated endocytosis to
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medium to replication organelles. Here, cholesterol regulates viral
polyprotein processing, facilitates and stimulates replication. Dis-
ruption of clathrin-mediated endocytosis triggers cholesterol sto-
rage in LDs. Consequently, cholesterol cannot be trafﬁcked to re-
plication organelles and replication is inhibited [62].
For intestinal viruses which need LDs for their production, it
will be interesting to examine the impact of the diet lipid content
on virus propagation and pathology.4. Conclusion
The mechanisms that control the lipid distribution in the var-
ious cellular compartments of enterocytes, and the consequences
of their alteration on physiopathology are still poorly understood.
LDs are now recognized as a transient storage lipid pool, highly
dynamic, and regulated by LD-associated proteins. In the past few
years, knowledge on enterocyte LD biology increased due to the
identiﬁcation of LD-associated proteins and to functional studies
of several of these proteins in the context of the intestine using
animal or cellular models. Results show that alteration of several
LD- associated proteins impacts chylomicron production. It can
also modify lipid uptake from the intestinal lumen, with possible
consequences on gut microbiota. LDs should be considered as a
possible target for improving metabolic health by nutritional and
nutraceutical recommendations.
LDs are associated to proteins involved in lipid metabolism but
also to many other proteins, involved in many pathways. The
functional signiﬁcance of the presence of these proteins on LDs in
the intestinal context remains to be studied.Conﬂict of interest
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